Sarepta Therapeutics stock trades at EUR 16.96 before earnings

Published on 11/05/2026 at 14:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sarepta Therapeutics stock faces its third-quarter results after the Nasdaq close on Thursday. Management will discuss the figures in an investor call.

Results Are Due After Nasdaq Close

Sarepta Therapeutics will release third-quarter results after the Nasdaq Global Market closes on Thursday.
Management is scheduled to discuss the results during a conference call at 4:30 p.m. Eastern Time.

SRPT, US8036071004, Illustration mit AI erstellt.

Sarepta Therapeutics stock traded at 16.96 euros on Lang & Schwarz at 14:14 CET on Thursday, November 5, 2026. The quote provides a current market reference ahead of the company's scheduled third-quarter report.

Sarepta announced on October 22 that it would release third-quarter 2026 financial results after the Nasdaq Global Market closes on Thursday, November 5. The company said management would host a conference call at 4:30 p.m. Eastern Time to discuss the figures, according to a Sarepta Therapeutics investor-relations release.

Investor Focus Turns To Results

The release and conference call are the next scheduled company communication for investors. Sarepta describes its business as focused on precision genetic medicines for rare diseases, with programs spanning Duchenne muscular dystrophy, muscle, central nervous system and cardiac diseases.

Investors can follow the real-time quote of Sarepta Therapeutics stock for subsequent trading updates.

Broader market sentiment can be followed through the S&P 500 market reports.

More news and analysis is available on Sarepta Therapeutics stock.